-
Lipopolysaccharide-induced HIV-1 expression in transgenic mice is mediated by tumor necrosis factor-alpha and interleukin-1, but not by interferon-gamma nor interleukin-6.
AIDS. 2000 Jul 7;14(10):1299-307
PMID: 10930143
-
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.
J Exp Med. 1999 Oct 4;190(7):995-1004
PMID: 10510089
-
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
Nature. 2000 Nov 30;408(6812):600-5
PMID: 11117749
-
Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention.
Arthritis Res. 1999;1(1):17-20
PMID: 11094408
-
The TNF and TNF receptor superfamilies: integrating mammalian biology.
Cell. 2001 Feb 23;104(4):487-501
PMID: 11239407
-
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Annu Rev Immunol. 2001;19:163-96
PMID: 11244034
-
Physiology of cytokine pathways in rheumatoid arthritis.
Arthritis Rheum. 2001 Feb;45(1):101-6
PMID: 11308054
-
Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis.
J Exp Med. 2002 Jul 1;196(1):77-85
PMID: 12093872
-
The paradigm of IL-6: from basic science to medicine.
Arthritis Res. 2002;4 Suppl 3:S233-42
PMID: 12110143
-
Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12287-92
PMID: 12221281
-
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Arthritis Rheum. 2002 Dec;46(12):3143-50
PMID: 12483717
-
Control of regulatory T cell development by the transcription factor Foxp3.
Science. 2003 Feb 14;299(5609):1057-61
PMID: 12522256
-
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.
Science. 2003 Feb 14;299(5609):1033-6
PMID: 12532024
-
Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.
Arthritis Rheum. 2003 Mar;48(3):594-601
PMID: 12632409
-
CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.
Arthritis Rheum. 2003 May;48(5):1452-60
PMID: 12746920
-
Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
J Immunol. 2003 Sep 1;171(5):2270-8
PMID: 12928371
-
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice.
Nature. 2003 Nov 27;426(6965):454-60
PMID: 14647385
-
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
J Exp Med. 1985 Dec 1;162(6):2163-8
PMID: 2999289
-
Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction.
Arthritis Rheum. 1988 Apr;31(4):480-6
PMID: 3258750
-
Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.
J Clin Invest. 1989 Feb;83(2):585-92
PMID: 2464001
-
Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis.
Ann Rheum Dis. 1989 Aug;48(8):645-53
PMID: 2675782
-
Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.
J Exp Med. 1990 Aug 1;172(2):537-45
PMID: 2373992
-
Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.
J Exp Med. 1991 Feb 1;173(2):487-9
PMID: 1703209
-
Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
Arthritis Rheum. 1991 Sep;34(9):1125-32
PMID: 1930331
-
The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium.
J Immunol. 1991 Dec 15;147(12):4207-10
PMID: 1721640
-
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
Science. 1993 Mar 19;259(5102):1739-42
PMID: 8456300
-
Interleukin-10-deficient mice develop chronic enterocolitis.
Cell. 1993 Oct 22;75(2):263-74
PMID: 8402911
-
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
Arthritis Rheum. 1993 Dec;36(12):1681-90
PMID: 8250987
-
Cytokine signal transduction.
Cell. 1994 Jan 28;76(2):253-62
PMID: 8293462
-
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
J Exp Med. 1994 May 1;179(5):1517-27
PMID: 8163935
-
The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice.
Eur J Immunol. 1995 Jun;25(6):1794-7
PMID: 7615010
-
Apoptosis in rheumatoid arthritis synovium.
J Clin Invest. 1995 Sep;96(3):1631-8
PMID: 7657832
-
Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.
Ann Rheum Dis. 1995 Aug;54(8):654-61
PMID: 7677442
-
Interleukin-10 inhibition of the progression of established collagen-induced arthritis.
Arthritis Rheum. 1996 Mar;39(3):495-503
PMID: 8607899
-
Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.
Arthritis Rheum. 1996 May;39(5):797-809
PMID: 8639177
-
Role of cytokines in rheumatoid arthritis.
Annu Rev Immunol. 1996;14:397-440
PMID: 8717520
-
Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line.
Transgenic Res. 1996 Nov;5(6):487-91
PMID: 8840532
-
Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats.
Scand J Immunol. 1996 Dec;44(6):607-14
PMID: 8972743
-
Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.
Arthritis Rheum. 1997 Feb;40(2):249-60
PMID: 9041936
-
Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA).
Clin Exp Immunol. 1997 Mar;107(3):507-12
PMID: 9067525
-
Rheumatoid factor autoantibodies in health and disease.
Ann N Y Acad Sci. 1997 Apr 5;815:296-311
PMID: 9186666
-
Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
Am J Pathol. 1997 Jul;151(1):177-91
PMID: 9212744
-
Interleukin 6 is required for the development of collagen-induced arthritis.
J Exp Med. 1998 Feb 16;187(4):461-8
PMID: 9463396
-
Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis.
J Infect Dis. 1998 Nov;178(5):1512-5
PMID: 9780277
-
Signal transduction and transcription factors in rheumatic disease.
Arthritis Rheum. 1999 Apr;42(4):609-21
PMID: 10211874
-
Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
J Immunol. 1999 Aug 1;163(3):1521-8
PMID: 10415055
-
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice.
Arthritis Rheum. 1999 Aug;42(8):1635-43
PMID: 10446862
-
Susceptibility to collagen-induced arthritis: cytokine-mediated regulation.
Clin Immunol. 2001 Jan;98(1):109-18
PMID: 11141333